BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2025 12:56:12 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-06-26 04:08 |
|
Peer-Review Started |
|
2025-06-26 04:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-07-10 05:55 |
|
Revised |
|
2025-07-13 12:42 |
|
Second Decision |
|
2025-09-24 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-09-24 07:27 |
|
Articles in Press |
|
2025-09-24 07:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-05 00:32 |
|
Publish the Manuscript Online |
|
2025-11-14 00:56 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Precision medicine advances in pancreatic cancer driven by genomic and molecular alterations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xiang Li, Yan Jiao and Ya-Hui Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ya-Hui Liu, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun 130021, Jilin Province, China. yahui@jlu.edu.cn |
| Key Words |
Pancreatic ductal adenocarcinoma; Precision medicine; Kirsten rat sarcoma viral oncogene homolog mutation; Breast cancer susceptibility gene mutation; Genomic profiling; Targeted therapy; Tumor mutational burden |
| Core Tip |
This review highlights the transformative impact of precision medicine in pancreatic ductal adenocarcinoma by focusing on clinically relevant genomic and molecular alterations such as Kirsten rat sarcoma viral oncogene homolog and breast cancer susceptibility gene mutations, rare actionable fusions, and co-mutational signatures. It emphasizes the importance of integrating routine molecular profiling into clinical workflows to guide targeted therapies and personalized treatment strategies. |
| Publish Date |
2025-11-14 00:56 |
| Citation |
<p>Li X, Jiao Y, Liu YH. Precision medicine advances in pancreatic cancer driven by genomic and molecular alterations. <i>World J Gastrointest Oncol</i> 2025; 17(11): 111264</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i11/111264.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i11.111264 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
